Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis

• Главные авторы: Johnson C (Автор), Stephens J (Автор), Walker C (Автор), Cappelleri JC (Автор), Shelbaya A (Автор)
• Формат: ‌
• Опубликовано: Dove Medical Press, 2020-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Courtney Johnson,1 Jennifer Stephens,1 Christopher Walker,2 Joseph C Cappelleri,3 Ahmed Shelbaya4 1Pharmerit International, Real World Evidence and Data Analytics, Bethesda, MD, USA; 2Pfizer Ltd., Global Medical Affairs, Tadworth, Surrey, England; 3Pfizer Inc., Statistics, Groton, CT, USA; 4Pfizer I...